ERBB2 and breast cancer: These results strongly indicated that Compound C did not reverse the anti-growth effect of aspirin on HER-2-positive breast cancer cells; in contrast, it strengthened the anti-proliferation and pro-apoptosis effects of aspirin in an alternative and AMPK-independent manner in HER-2-positive breast cancer cells.